Discover
ALLR
Allarity Therapeutics, Inc.
1.22
14 x 1.20
2 x 1.34
bid
ask
+
0.00
0.00%
08:37 AM
timesize
| Ytd | 12.96% | |
| 1y | 25.77% |
1.20
day range
1.24
0.77
52 week range
2.35
| Open | 1.22 | Prev Close | 1.22 | Low | 1.20 | High | 1.24 | Mkt Cap | 19.41M |
| Vol | 67.00 | Avg Vol | 190.64K | EPS | -0.70 | P/E | -1.74 | Forward P/E | -0.02 |
| Beta | 0.53 | Short Ratio | 0.30 | Inst. Own | 2.21% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 1.42 | 200-d Avg | 1.25 | 1yr Est | 5.00 |
| Income Statement | |||
| Total Revenue | 25.00K | ||
| Revenues (USD) | 25.00K | ||
| Gross Profit | 25.00K | ||
| Operating Expenses | 2.71M | ||
| Research and Development Expense | 1.30M | ||
| Selling, General and Administrative Expense | 1.42M | ||
| Operating Income | -2.69M | ||
| Interest Expense | 229.00K | ||
| Net Income | -2.75M | ||
| Net Income Common Stock | -2.75M | ||
| Net Income Common Stock (USD) | -2.75M | ||
| Consolidated Income | -2.75M | ||
| Earnings per Basic Share | -0.17 | ||
| Earnings per Basic Share (USD) | -0.17 | ||
| Earnings per Diluted Share | -0.17 | ||
| Earning Before Interest & Taxes (EBIT) | -2.52M | ||
| Earning Before Interest & Taxes (USD) | -2.52M | ||
| Weighted Average Shares | 15.97M | ||
| Weighted Average Shares Diluted | 15.97M | ||
| Balance Sheet | |||
| Cash and Equivalents | 29.81M | ||
| Cash and Equivalents (USD) | 29.81M | ||
| Current Assets | 34.50M | ||
| Property, Plant & Equipment Net | 420.00K | ||
| Total Assets | 34.92M | ||
| Debt Current | 21.50M | ||
| Total Debt | 21.50M | ||
| Current Liabilities | 28.00M | ||
| Total Liabilities | 28.00M | ||
| Accumulated Retained Earnings (Deficit) | -132.95M | ||
| Accumulated Other Comprehensive Income | -1.08M | ||
| Shareholders Equity | 6.92M | ||
| Shareholders Equity (USD) | 6.92M | ||
| Assets Non-Current | 420.00K | ||
| Total Debt (USD) | 21.50M | ||
| Trade and Non-Trade Payables | 4.24M | ||
| Tax Assets | 1.08M | ||
| Tax Liabilities | 81.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | -26.00K | ||
| Net Cash Flow from Financing | 19.74M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 15.18M | ||
| Capital Expenditure | -64.00K | ||
| Issuance (Purchase) of Equity Shares | -260.00K | ||
| Issuance (Repayment) of Debt Securities | 20.00M | ||
| Net Cash Flow from Investing | -64.00K | ||
| Net Cash Flow from Operations | -4.49M | ||
| Effect of Exchange Rate Changes on Cash | -58.00K | ||
| Share Based Compensation | 160.00K | ||